...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Zenith AGM

Zenith announced AGM October 31 in Calgary, as did Resverlogix. No time announced for Zenith but Resverlogix is 1PM. After both AGMs DM will give a corporate update presentation.

Sorry I am not sure how to post the announcement myself.

 

GLTA

Share
New Message
Please login to post a reply